Monday, April 10, 2017

Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 3

If you are unable to see the message below, click here to view.
Cancer Gene Therapy

A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine.

Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.

Open for submissions >> 


Volume 24, Issue 3 (March 2017)

In this issue

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective

Richard P Junghans

Cancer Gene Ther 2017 24: 89-99; 10.1038/cgt.2016.82

Full Text



Myeloid-derived suppressor cells and their role in pancreatic cancer

M Pergamo and G Miller

Cancer Gene Ther 2017 24: 100-105; advance online publication, December 2, 2016; 10.1038/cgt.2016.65

Abstract | Full Text

T-cell programming in pancreatic adenocarcinoma: a review

Y D Seo and V G Pillarisetty

Cancer Gene Ther 2017 24: 106-113; advance online publication, December 2, 2016; 10.1038/cgt.2016.66

Abstract | Full Text

Immunosuppression in liver tumors: opening the portal to effective immunotherapy

P Guha, J Reha and S C Katz

Cancer Gene Ther 2017 24: 114-120; advance online publication, December 2, 2016; 10.1038/cgt.2016.54

Abstract | Full Text

Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them

S Sengupta, G Mao, Z S Gokaslan and P Sampath

Cancer Gene Ther 2017 24: 121-129; advance online publication, October 21, 2016; 10.1038/cgt.2016.46

Abstract | Full Text

Current status of immunotherapy for gastrointestinal stromal tumor

Y Tan, J C Trent, B A Wilky, D A Kerr and A E Rosenberg

Cancer Gene Ther 2017 24: 130-133; advance online publication, February 10, 2017; 10.1038/cgt.2016.58

Abstract | Full Text

Gene-expression profiling to predict responsiveness to immunotherapy

N B Jamieson and A V Maker

Cancer Gene Ther 2017 24: 134-140; advance online publication, November 11, 2016; 10.1038/cgt.2016.63

Abstract | Full Text

Combinatorial immunotherapy for melanoma

D D George, V A Armenio and S C Katz

Cancer Gene Ther 2017 24: 141-147; advance online publication, November 11, 2016; 10.1038/cgt.2016.56

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group

No comments: